Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Authors:
Top Cited Papers
Open Access
- 20 January 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 19 (1) , 1-24
Abstract
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. The pathological hallmark of PD is loss of dopaminergic neurons and the presence of aggregated α-synuclein, primarily in the substantia nigra pars compacta (SNpc) of the midbrain. However, the molecular mechanisms that underlie the pathology in different cell types is not currently understood. Here, we present a single nucleus transcriptome analysis of human post-mortem SNpc obtained from 15 sporadic Parkinson’s Disease (PD) cases and 14 Controls. Our dataset comprises ∼84K nuclei, representing all major cell types of the brain, allowing us to obtain a transcriptome-level characterization of these cell types. Importantly, we identify multiple subpopulations for each cell type and describe specific gene sets that provide insights into the differing roles of these subpopulations. Our findings reveal a significant decrease in neuronal cells in PD samples, accompanied by an increase in glial cells and T cells. Subpopulation analyses demonstrate a significant depletion of tyrosine hydroxylase (TH) enriched astrocyte, microglia and oligodendrocyte populations in PD samples, as well as TH enriched neurons, which are also depleted. Moreover, marker gene analysis of the depleted subpopulations identified 28 overlapping genes, including those associated with dopamine metabolism (e.g., ALDH1A1, SLC6A3 & SLC18A2). Overall, our study provides a valuable resource for understanding the molecular mechanisms involved in dopaminergic neuron degeneration and glial responses in PD, highlighting the existence of novel subpopulations and cell type-specific gene sets.Keywords
All Related Versions
Funding Information
- Stichting Alzheimer Onderzoek (20200034, 2020/017)
- Fundação para a Ciência e a Tecnologia (2020.08750BD)
- Fonds Wetenschappelijk Onderzoek (G0F8516N, G065721N)
- KU-Leuven Internal Funding (C14/17/107, C14/22/132, C3/20/057)
- Bit Bio Ltd (RRAG/257)
- Welcome Trust (RG86251)
- Open Targets (OTAR2052)
- European Commission (H2020 WIDESPREAD-2018-2020-6, NCBio, 951923)
- UK Dementia Research Institute (RRZA/175)
- VIB Tech Watch
This publication has 75 references indexed in Scilit:
- Orchestration of Neurodevelopmental Programs by RBFOX12013
- CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse modelNeuroscience Letters, 2012
- Up-regulation of metallothionein gene expression in Parkinsonian astrocytesneurogenetics, 2011
- Golgi GlycosylationCold Spring Harbor Perspectives in Biology, 2011
- Microglial responses to dopamine in a cell culture model of Parkinson's diseaseNeurobiology of Aging, 2009
- The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasisProceedings of the National Academy of Sciences, 2008
- Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradationMedicinal Research Reviews, 2005
- Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's diseaseThe FASEB Journal, 2005
- Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental ParkinsonismGene Therapy, 1998
- Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line: In vitro characterization and engraftment into the rodent striatumCell Transplantation, 1996